- 2022 - 2025 最新プロテオミクスによる肺アミロイドーシスのバイオマーカーの探索
- 2022 - 2025 次世代プロテオミクスが紐解く個別化医療に有用なPF-ILDの新規BM開発
- 2019 - 2023 トランスオミクスが紐解くCOPDの新規バイオマーカーと病態解明
- 2019 - 2022 Identification of novel biomarkers for lymphangioleiomyomatosis from extracellular vesicles by comprehensive approach .
- 2016 - 2019 Elucidation of the roles of tetraspanins and vesicle transport in the tumor progression of lymphanigoleiomyomatosis.
- 2016 - 2019 Exploration of innovative biomarkers in pulmonary fibrosis by quantitative proteomics of exosomes
- 2015 - 2018 Proteomics of peripheral exosome identifies novel biomarkers for COPD
- 2015 - 2018 Analysis of immune response against cancer, which may lead to establishment of WT1 peptide-based immunotherapy for the conventional treatment-resistant malignancies in the respiratory medicine field
- 2012 - 2016 Development of preclinical system based on pulmonary functional imaging by hyperpolarized Xe MRI
- 2012 - 2015 Development of WT1 peptide-based immunotherapy for inoperable thoracic malignant tumors, and analysis of immunodynamics of the novel therapy
- 2012 - 2015 Role of adiponectin in COPD
- 2012 - 2013 テトラスパニンに作用するCOPD治療薬の探索
- 2009 - 2011 Functional analysis of tetraspanins(CD9, CD151) in lung fibrosis
- 2009 - 2011 Cancer antigen WT1-targeting peptide vaccine therapy for lung cancer
- 2008 - 2010 Role or tetraspanins in angiogenesis and lymphangiogenesis
- 2008 - 2010 Mechanisms of lung inflammation in tetraspanin-knockout mice
- 2007 - 2008 Development of WT1 peptide cancer vaccine targeting lung cancer
Show all